Your email has been successfully added to our mailing list.

×
0 0 0 0 -0.1 -0.0818181818181819 -0.0545454545454546 -0.090909090909091
Stock impact report

CTI Bio down 8% premarket on withdrawal of pacritinib application in Europe [Seeking Alpha]

CTI BioPharma Corp. (CTIC) 
Last cti biopharma corp. earnings: 11/1 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: ctibiopharma.com
Company Research Source: Seeking Alpha
CTI Bio down 8% premarket on withdrawal of pacritinib application in Europe Thinly traded nano cap CTI BioPharma (NASDAQ: CTIC 8% withdrawal The company is staying the course with pacritinib, a kinase inhibitor, in myelofibrosis patients with severe thrombocytopenia. A Phase 3 trial should commence in Q3. Show less Read more
Impact Snapshot
Event Time:
CTIC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for CTIC alerts
Opt-in for
CTIC alerts

from News Quantified
Opt-in for
CTIC alerts

from News Quantified